首页> 外国专利> ANTI-CANCER COMPOSITION FOR OSTEOSARCOMA USING MIXED EXTRACT INCLUDING SAURURUS CHINENSIS AND SCUTELLARIA BAICALENSIS

ANTI-CANCER COMPOSITION FOR OSTEOSARCOMA USING MIXED EXTRACT INCLUDING SAURURUS CHINENSIS AND SCUTELLARIA BAICALENSIS

机译:混合使用提取物包括中华模骨和黄SC的骨肉瘤抗癌组合物

摘要

In the present invention, disclosed is an anticancer composition for osteosarcoma using the extract of a mixture of Saururus chinensis, Scutellaria baicalensis, Prunella vulgaris, Lithospermum officinale, pericarp of Citrus nippokoreana, and Portulaca oleracea. The anticancer composition of the present invention, unlike pre-existing anticancer drugs based on apoptosis and inhibitory activities on cancer cells, works on cancer stem cells that cause resistance to anticancer drugs, and induces apoptosis thereof, and inhibits proliferation and metastasis thereof, thereby suppressing metastasis and relapse of cancer that have been the limit of pre-existing anticancer drugs, and thus has promising possibility of a fundamental treatment of cancer. Further, the anticancer composition shows no toxicity to normal cells, and has no noticeable effects on the proliferation of normal cells, and thus can have no side effects such as hair loss, nausea, and stomatitis that are typically caused by the toxicity that pre-existing anticancer drugs based on apoptosis activities on cancer cells have on normal cells.;COPYRIGHT KIPO 2017
机译:在本发明中,公开了使用龙骨,黄cut,夏枯草,紫草,桔皮,果皮和马齿Port的混合物的提取物的骨肉瘤抗癌组合物。与基于凋亡和对癌细胞的抑制活性的现有抗癌药不同,本发明的抗癌组合物作用于引起对抗癌药具有抗性并诱导其凋亡,抑制其增殖和转移的癌干细胞。癌症的转移和复发已成为现有抗癌药物的局限性,因此有可能成为癌症基本治疗方法。此外,该抗癌组合物对正常细胞没有毒性,对正常细胞的增殖也没有明显影响,因此不会有通常由毒性引起的副作用,例如脱发,恶心和口腔炎。现有的基于癌细胞凋亡活性的抗癌药物在正常细胞上具有作用;; COPYRIGHT KIPO 2017

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号